Clinical Trials
19 trialsNCT04037436 2025-04-13
MoveStrong
University of Waterloo
Phase NA Completed
NCT04663685 2024-05-13
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.
University of Waterloo
Phase NA Completed
NCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT02789800 2022-11-03
PACEinMM-QC
Université de Sherbrooke
Phase NA Completed
NCT02538341 2021-11-23
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
University of Alabama at Birmingham
Phase 2 Completed
NCT01960855 2021-08-24
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
AbbVie
Phase 2 Completed
NCT03601611 2020-04-21
COLAR
Herlev Hospital
Phase NA Completed
NCT03912168 2020-03-19
Question Prompt List for Orthopaedic Conditions
Stanford University
Phase NA Completed
NCT02819011 2020-02-27
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Baylor College of Medicine
Phase 2 Completed
NCT02500641 2019-06-21
FORWARD
Menarini International Operations Luxembourg SA
Phase 4 Completed
NCT02083861 2018-05-07
Wearable LITUS Device for Osteoarthritis of the Knee: a Randomized Double-Blind Placebo-Controlled Trial
ZetrOZ, Inc.
Phase NA Completed
NCT02933307 2017-04-25
Continuous Monitoring on the General Ward
Radboud University Medical Center
Phase NA Completed
NCT01351480 2017-03-13
Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients
Arthritis & Rheumatic Disease Specialties Research
Phase 3 Completed
NCT02036866 2015-12-14
Corticospinal Excitability and Rehab in Knee Osteoarthritis
Creighton University
Phase NA Completed
NCT02144272 2015-07-17
Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis
Eli Lilly and Company
Phase 1 Completed
NCT00004409 2015-03-25
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00014742 2015-03-25
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 3 Completed
NCT00696059 2008-06-12
HURRAH
Hvidovre University Hospital
Phase 4 Completed
NCT00017680 2008-06-09
Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis
Office of Rare Diseases (ORD)
Phase 2 Completed